Medindia
Medindia LOGIN REGISTER
Advertisement

Companion Diagnostics: Biomarker Platforms Enabling Precision Medicine

Monday, November 19, 2018 General News
Advertisement
NEW YORK, Nov. 19, 2018 /PRNewswire/ -- Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy
Advertisement

Both predictive and prognostic biomarkers constitutes an central element in each and every targeted oncology drug discovery and development program.Breakthrough technologies allowing leveraging biomarkers for oncology are paving the way of personalized medicine and precision oncology.Read the full report: https://www.reportlinker.com/p05623085 Indeed, oncology biomarkers provide the clinical community with the opportunity to offer individualized therapies and health programs. Furthermore, oncology biomarkers enable to get critical information about the mechanism of action of a drug or target, to profoundly study carcinogenesis process, and to match patient characteristics specifically to the most appropriate treatment.Read the full report: https://www.reportlinker.com/p05623085 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement

Cision View original content:http://www.prnewswire.com/news-releases/companion-diagnostics-biomarker-platforms-enabling-precision-medicine-300753032.html

SOURCE Reportlinker

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close